UNICEF 2017 VACCINE INDUSTRY CONSULTATION October 2017 UNICEF Supply Division, Oceanvej 10-12, 2150, Nordhavn, Copenhagen, Denmark

Similar documents
VACCINE MARKETS OVERVIEW SESSION

Information for Access

Managing constrained vaccine supply: prevention and remediation Lessons learned and ways forward DVCMN Annual Meeting October Bangkok,

WHO Update Tania Cernuschi & Patrick Lydon

Gavi Secretariat Update: Progress, priorities and strategies

Perspectives on Ensuring Access to Vaccines in Lower Income Countries

TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

GAVI Role in IPV Introductions

Gavi initiatives for improving vaccine supply

How does Gavi make vaccine investment decisions?

UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013

Update on Polio Vaccine Supply

Access to affordable vaccines in Emergency and Humanitarian Response June 20, 2016

PROPOSED AGENDA. PROPOSED AGENDA AGM 24-27th October 2016, Buenos Aires

Oral Polio Vaccine Supply Outlook. UNICEF Supply Division

Vaccines Supply Shortages Challenges & Opportunities

Gavi s private sector engagement approach

GAVI, THE VACCINE ALLIANCE

Nutrition Procurement Overview

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer

Report to the Board 6-7 June 2018

IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION. GAVI Board - 13 June 2017, Geneva

Overview of Measlescontaining. through UNICEF. Overview of [VACCINE] through UNICEF

WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES

Protecting people against known and emerging infectious diseases globally

Vaccine Development in the Developing World; past, present and future: SEAR Perspective

Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012

Report to the. GAVI Alliance Board November 2013

The Financial Sustainability of New Vaccine Introduction in the Poorest Countries :

Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 6 8 November 2012 CCV/CICG, Geneva

Report to the. GAVI Alliance Board June 2013

Inaugural Keynote Lecture: Contributions of Gavi and DCVMN to the global vaccine markets

REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition

JOINT WHO & UNAIDS ANNUAL CONSULTATION WITH PHARMACEUTICAL COMPANIES ON GLOBAL FORECASTS OF ANTIRETROVIRAL DEMAND

Presentation to 13th Annual General Meeting of the DCVMN UNICEF Vaccine Forecasting

The art of partnerships Program Agenda

MARKET UPDATE: ROUTINE VACCINE INTRODUCTIONS PCV HPV ROTA

GAVI s Financing for Pneumococcal Vaccines, including the Advance Market Commitment

GAVI Alliance. Aurelia Nguyen, Director Policy & Market Shaping. IPC Meeting 30 May 2013

Saving lives through immunisation A Corporate Social Responsibility approach

Polio post-certification strategy

Global Health Policy: Vaccines

Gavi s strategic framework 22 June 2016

Hepatitis A. Rabies and. Seasonal Influenza Vaccines Vaccine Industry Consultation October 2018

Polio and routine immunisation Alan Brooks

Draft Programme (05 May 2016)

Safe Injection Equipment

Update on polio vaccine supply & forecast

Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 1 3 April 2014 CCV/CICG, Geneva

Responding to the SAGE Recommendations on Middle Income Countries Since Sarah Schmitt WHO Consultant

2016 NON FINANCIAL RESOURCE REQUIREMENTS GPEI DONOR CONTRIBUTIONS

Yellow Fever Vaccine: Current Outlook. UNICEF Supply Division

Pentavalent Market. UNICEF/UN074464/Lister. UNICEF SUPPLY DIVISION 2018 Vaccine Industry Consultation

Report to the Board 6-7 June 2018

Aboubacar Kampo Chief of Health UNICEF Nigeria

GAVI, THE VACCINE ALLIANCE

Bureau Advisory Group Meeting 4 March 2019

Update on Implementation of NUV. Carsten Mantel WHO/FCH/IVB/EPI

The art of partnerships Program Agenda

1. The World Bank-GAVI Partnership and the Purpose of the Review

FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department

Gian Gandhi. Vaccine Pre tender Meeting UNICEF Supply Division

Establishing a cholera stockpile: What do we need? Alejandro Costa Epidemic Readiness and Intervention

DRAFT UNICEF PROCUREMENT OF HIV/AIDS-RELATED SUPPLIES AND SERVICES

5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)

Immunization Financing Outlook: A Historical Perspective

Access to vaccination in GAVI countries and at global level

used for HPV vaccine delivery to identify best practices and inform efforts to improve HPV vaccine coverage nationwide.

Global Health Policy: Vaccines

Diagnostics product development projects

Development of Vaccine Security at the Regional Level

Vaccination in acute humanitarian emergencies

6 Opportunities for Improving Pathways to Market: A Global Perspective on Dementia

41 st Annual Conference UN MUNDO, MUCHAS VOCES (ONE WORLD, MANY VOICES) November 1-4, 2018 Puebla, Mexico. A Guide for Partners

GAVI Alliance Demand-side Innovation Policies

The Economic and Social Council, Recalling the United Nations Millennium Declaration13 and the 2005 World Summit Outcome, 1

The power of innovation to save lives

Wins and Challenges: Reflections on the 2018 State Legislative Sessions. Thursday, June 14, :00 pm - 2:00 pm EDT

Innovative Finance: the power of innovation to save lives

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

Gavi s Sustainability and Transition Approach

3. CONCLUSIONS AND RECOMMENDATIONS

Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV

POLIO ERADICATION AND POST-CERTIFICATION STRATEGY

From Vaccine Development to Policy: A Brief Review of WHO Vaccine-Related Activities and Advisory Processes (2017)

Report to the Board June 2016

What is to be done to respond to country needs and comply with WHA and SAGE recommendations?

Collaborative procedure for licensing Prequalified vaccines

The power of partnership: the GAVI Alliance Board

MALARIA VACCINE PILOTS

Meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization Agenda October 2018 CICG, Geneva, Switzerland Version: 19 October 2018

Rotavirus Vaccine. Supply and Procurement Roadmap. The Market Shaping Goal. Public Summary. Rotavirus Supply and Procurement Roadmap UPDATE 2016

Gavi s Vaccine Investment Strategy

Report to the Board June 2015

Monitoring of the achievement of the health-related Millennium Development Goals

Message from. Dr Samlee Plianbangchang Regional Director, WHO South-East Asia. At the. Regional Review Meeting on Immunization

GOTHENBURG April Sponsorship & Exhibition Opportunities

How to present the European Vaccine Action Plan (EVAP)

The art of partnerships Program Agenda

Transcription:

UNICEF 2017 VACCINE INDUSTRY CONSULTATION 05-06 October 2017 UNICEF Supply Division, Oceanvej 10-12, 2150, Nordhavn, Copenhagen, Denmark AGENDA INTRODUCTION UNICEF works in 190 countries and territories to protect the rights of every child. It operates in more than 130 countries, supporting governments to achieve a state where no child dies from a preventable cause, and all children reach their full potential in health and well-being. UNICEF Supply Division has a key role in procurement of vaccines and immunization supplies on behalf of 100 countries annually, supplying over 2.5 billion doses of vaccines in support of routine immunization programs, preventive campaigns, outbreak and emergency response activities. To maximise results, UNICEF Supply Division works in partnership with countries, Non-Governmental Organizations and suppliers. The Vaccine Industry Consultation provides information that prepares the vaccine market for future UNICEF procurements, and presents a platform for suppliers to contribute to solutions that optimize product quality, offer value for money and support end-to-end supply chain. The forum also engages with suppliers to discuss progress for ongoing and planned procurements. The theme for the 2017 Vaccine Industry Consultation will be Regulatory System Strengthening: operational challenges in response to suppliers who had indicated the need to have a more interactive discussion with stakeholders on challenges for suppliers on changes to country regulatory requirements when supplying through UN Agencies. Additional objectives for the VIC are to provide vaccine market updates to the industry; integrate the consultation with the Vaccine Procurement Practitioners Exchange Forum (VPPEF) to foster constructive discussions between Middle Income Country representatives and the industry; and update on the status of access to affordable vaccine for humanitarian emergencies. The first day (October 5 th ) of the Vaccine Industry Consultation will be dedicated to informative and interactive plenary sessions, including presentations by UNICEF and partners, followed by a panel discussion on Regulatory System Strengthening. The second day (October 6 th ) will feature vaccine market updates in addition to a series of sessions running consecutively. The main benefit of these sessions will be to generate reactions and reflections on specific topics by increasing participants ability to attend sessions that are most relevant to their interests and allocating sufficient time for Q&As and in-depth discussions. A Market Place with overviews of all the vaccines UNICEF procures will be available throughout the day, manned by UNICEF staff to respond to question by suppliers.

Specific objectives 1) UNICEF Update To ensure the industry is updated on the latest developments in programs and procurement from UNICEF (both Supply and Program Divisions). 2) 2017 theme: Regulatory System Strengthening To provide constructive discussions on current regulatory challenges and strategic options to be considered to further improve in-country access to supply. 3) Partner Updates To provide an opportunity for partners to update industry on recent developments and initiatives to achieve the goal of supply security of quality assured, affordable vaccine. Expected outcomes of the meeting 1. Industry is informed on upcoming tenders and specific vaccine market updates. 2. Industry is informed on program direction, including EPI, humanitarian emergency responses and emergency stockpiles that will influence vaccine markets. 3. Suppliers are informed of structural changes (i.e. Freight Forwarders and terms and conditions of agreements). 4. Regulatory related issues are presented and concrete solutions are discussed. 5. Partners and industry are informed on innovations led by UNICEF in procurement to meet the programme goals and objectives, including those of the Gavi Supply and Procurement Strategy 2016-2020, and ensure the most optimal products are available for children. 1 P a g e

Target Audience October 4 th will be open to vaccine industry (manufacturers), to selected vaccine procurement practitioners from Middle Income Countries and to UNICEF. October 5 th and 6 th will be open to vaccine industry, UNICEF and partner organisations. Meeting with buyers Wednesday 4 October 2017 8:30 9:00 REGISTRATION 9:00 10:00 SESSION ON REGULATORY SYSTEMS ISSUES Heather Deehan, Chief, Vaccine Centre 10:00-12:00 BI-LATERAL MEETINGS With national vaccine buyers (Middle Income Countries) 12:00: 13:00 Lunch 13:00 18:00 BI-LATERAL MEETINGS With national vaccine buyers (Middle Income Countries) Day 1 Thursday 5 October 2017 8:30 9:00 REGISTRATION 9:00 9:20 WELCOME AND OVERVIEW OF UNICEF SUPPLY FUNCTION Suvi Rautio, Deputy Director Supply Programme, Director s Office, UNICEF Supply Division. 9:20 10:50 SESSION 1: UNICEF UPDATE Heather Deehan, Chief, Vaccine Centre Robin Nandy, Principle Advisor, Immunization 10:50 11:00 Break 11:00 11:30 SESSION 2: WHO UPDATE Patrick Lydon, Supply, Technologies & Financing (STF) team Expanded Programme on Immunization (EPI) Tania Cernuschi, Technical Officer, Vaccine Pricing, Supply, Procurement 11:30 12:00 SESSION 3: GAVI UPDATE Melissa Malhame, Head of Market Shaping 2 P a g e

12:00 12:15 SESSION 4: UNICEF S PERSPECTIVE ON REGULATORY SYSTEMS STRENGTHENING Ann Ottosen, Senior Manager, UNICEF Supply Division 12:15 13:15 Lunch (Warehouse Tour) 13:15 16:15 SESSION 5: REGULATORY SYSTEMS STRENGTHENING WHO Regulatory System Strengthening (RSS) Developing Country Vaccine Manufacturers Network (DCVMN) International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) WHO Pre-qualification Team (PQT) Bill and Melinda Gates Foundation (BMGF) (tbc) 16:15 16:30 CLOSE Heather Deehan, Chief, UNICEF Supply Division 16:30 18:00 BI-LATERAL MEETINGS Day 2 Friday 6 October 2017 8:30 9:00 REGISTRATION 9:00 10:00 SESSION 6: UNICEF MARKET UPDATES HPV David Kiambi Mutuerandu Pentavalent Yalda Momeni Cholera Guillermo Gimeno Japanese Encephalitis (JE) Abraham Kofi Ntow 10:00 11:00 SESSION 7: EMERGENCY STOCKPILES AND VACCINE RESEARCH AND DEVELOPMENT Hans Christiansen, Vaccine Centre Stockpile Management: lessons learned and path forward Paul Wilson Vaccine development: Emergency stockpiles and consideration for UNICEF 3 P a g e

11:00 12:00 SESSION 8 (two parallel-sessions) Polio Ann Ottosen, Senior Manager, Polio Unit, Vaccine Centre, UNICEF Supply Division Rosamund Lewis, WHO bopv Andisheh Ghazieh, Contracts Officer, UNICEF IPV Ian Lewis, Contracts Specialist, UNICEF Introduction of new suppliers to UNICEF procurement mechanisms David Kiambi Mutuerandu, Contracts Manager, UNICEF Supply Division 12:00 12:15 CLOSE Etleva Kadilli, Director, UNICEF Supply Division Participants will have the option to attend additional Sessions, schedule a side-meeting with UNICEF or visit the Market Place as below described. 4 P a g e

Day 2 Friday 6 October 2017 SESSION OPTIONS 12:15-13:00 LUNCH 13:00-13:30 Coalition for Epidemiologic Preparedness Innovations (CEPI) 13:35-14:05 MSF: Patents and Vaccine Development 14:10-14:40 Global Health Investment Fund 14:45 15:15 Supplier Performance Scorecard MARKET PLACE SIDE- MEETINGS WITH UNICEF